ArticleSurgery open science2026
Stent-bridging fistulogastrostomy for refractory post-pancreatectomy external pancreatic fistula.
Article in Surgery open science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives: External pancreatic fistula (EPF) is a common consequence of partial pancreatectomy or percutaneous treatments for infected pancreatic necrosis. It has traditionally been treated surgically with distal pancreatectomy, Roux-en-Y pancreaticoenterostomy, or fistuloenterostomy. Methods and results: This study introduces a novel technique of laparoscopic stent-bridging fistulogastrostomy, which was used for a 40-year-old female experiencing refractory post-pancreatectomy high-output EPF. We present a standardized management protocol for this procedure, which includes preoperative clinical and radiologic diagnosis of disconnected pancreatic duct syndrome and persistent EPF, detailed surgical steps with technical tips accompanied by a video demonstration, and perioperative care to facilitate postoperative recovery. The patient's postoperative course was uneventful. This technique simplifies a challenging and complex procedure, making it reproducible and teachable. Conclusion: This novel technique provides a minimally invasive surgical solution for refractory EPF. Our experience shows that stent-bridging fistulogastrostomy is simple, safe, and effective. Further prospective studies are warranted to validate its long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.